High-risk papillomavirus infection is associated with altered antibody responses in genital tract:: Non-specific responses in HPV infection

被引:10
作者
Bard, E
Riethmuller, D
Meillet, D
Prétet, JL
Schaal, JP
Mougin, C
Seillès, E
机构
[1] Lab Univ Immunol EA 3181, Fac Med Pharm, F-25030 Besancon, France
[2] CHU Besancon, Hop St Jacques, Serv Gynecol Obstet, Besancon, France
[3] Fac Med Pharm, Lab Parasitol Mycol EA 482, Besancon, France
关键词
D O I
10.1089/0882824041856996
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In order to gain more information about local humoral immune responses to HPV infection, we quantified IgG, IgM, secretory-IgA (S-IgA), and total-IgA by ELISA, and lysozyme and lactoferrin by TR-IFMA, in cervical and cervicovaginal secretions of 40 healthy women and 28 high-risk HPV infected patients (11 were HPV16(+)). IgG, total-IgA, and S-IgA concentrations in cervicovaginal secretions (p<0.0001) and high IgG and total-IgA concentrations (p<0.001 and p<0.01, respectively) in endocervical secretions were significantly higher in HPV+ patients than in the healthy group. Since the S-IgA/total-IgA ratio was significantly lower in cervicovaginal (7.5%) and endocervical secretions (36.5%) in HPV women compared to the control group (p<0.003 and p<0.001, respectively), HPV could be responsible for an increase in local production of non-secretory IgA (monomeric and dimeric forms). IgG and total-IgA concentrations in cervicovaginal and endocervical secretions fell in the same general percentage range in both HPV16(+) and HPV+ groups (80% and 15%, respectively). However, the S-IgA/total-IgA ratio was much lower in HPV16(+) than in HPV+ women, in both cervicovaginal secretions (3.4%) (p<0.003) and in endocervical secretions (23.3%) (p<0.001). Innate immunity proteins and local S-IgA response could not stop the spread of HPV infection in spite of high lysozyme and lactoferrin concentrations. HPV16(+) disturbed the local humoral immune system, which could partly explain its low clearance.
引用
收藏
页码:381 / 389
页数:9
相关论文
共 43 条
  • [1] PROTEIN-SPECIFIC CERVICAL ANTIBODY-RESPONSES TO PRIMARY GENITAL HERPES-SIMPLEX VIRUS TYPE-2 INFECTIONS
    ASHLEY, RL
    COREY, L
    DALESSIO, J
    WILSON, P
    REMINGTON, M
    BARNUM, G
    TRETHEWEY, P
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1994, 170 (01) : 20 - 26
  • [2] Validation of a high sensitive immunoenzymatic assay to establish the origin of immunoglobulins in female genital secretions
    Bard, E
    Riethmuller, D
    Biichlé, S
    Meillet, D
    Prétet, JL
    Mougin, C
    Seillès, E
    [J]. JOURNAL OF IMMUNOASSAY & IMMUNOCHEMISTRY, 2002, 23 (02) : 145 - 162
  • [3] Nonspecific secretory immunity in HIV-infected patients with oral candidiasis
    Bard, E
    Laibe, S
    Clair, S
    Biichlé, S
    Millon, L
    Drobacheff, C
    Bettinger, D
    Seillès, E
    Meillet, D
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 (03) : 276 - 284
  • [4] BELEC L, 1994, J CLIN MICROBIOL, V32, P1249
  • [5] CERVICOVAGINAL OVERPRODUCTION OF SPECIFIC IGG TO HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) CONTRASTS WITH NORMAL OR IMPAIRED IGA LOCAL RESPONSE IN HIV-INFECTION
    BELEC, L
    DUPRE, T
    PRAZUCK, T
    TEVIBENISSAN, C
    KANGA, JM
    PATHEY, O
    LU, XS
    PILLOT, J
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (03) : 691 - 697
  • [6] Human T-lymphotropic virus type I excretion and specific antibody response in paired saliva and cervicovaginal secretions
    Belec, L
    Georges, AJ
    Hallouin, MC
    Mohamed, AS
    MorandJoubert, L
    GeorgesCourbot, MC
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1996, 12 (02) : 157 - 167
  • [7] Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia II. Systemic but not local IgA responses correlate with clearance of HPV-16
    Bontkes, HJ
    de Gruijl, TD
    Walboomers, JMM
    Schiller, JT
    Dillner, J
    Helmerhorst, TJM
    Verheijen, RHM
    Scheper, RJ
    Meijer, CJLM
    [J]. JOURNAL OF GENERAL VIROLOGY, 1999, 80 : 409 - 417
  • [8] PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE
    BOSCH, FX
    MANOS, MM
    MUNOZ, N
    SHERMAN, M
    JANSEN, AM
    PETO, J
    SCHIFFMAN, MH
    MORENO, V
    KURMAN, R
    SHAH, KV
    ALIHONOU, E
    BAYO, S
    MOKHTAR, HC
    CHICAREON, S
    DAUDT, A
    DELOSRIOS, E
    GHADIRIAN, P
    KITINYA, JN
    KOULIBALY, M
    NGELANGEL, C
    TINTORE, LMP
    RIOSDALENZ, JL
    SARJADI
    SCHNEIDER, A
    TAFUR, L
    TEYSSIE, AR
    ROLON, PA
    TORROELLA, M
    TAPIA, AV
    WABINGA, HR
    ZATONSKI, W
    SYLLA, B
    VIZCAINO, P
    MAGNIN, D
    KALDOR, J
    GREER, C
    WHEELER, C
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11): : 796 - 802
  • [9] Brandtzaeg P, 1997, Behring Inst Mitt, P1
  • [10] Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer
    Combita, AL
    Bravo, MM
    Touzé, A
    Orozco, O
    Coursaget, P
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 97 (06) : 796 - 803